SCHEMBL4209326

SCHEMBL4209326

CC(=O)CCC1NC(=O)N(C)CCCCC=CC2CC2(C2CC2(C=O)S(N)(=O)=O)NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207209 0.93 — —
SCHEMBL4187252 0.88 — —
SCHEMBL4189690 0.78 CTSB (0.31) —
SCHEMBL4221020 0.77 CTSB (0.33) —
SCHEMBL4180941 0.77 CTSB (0.33) —
SCHEMBL4221024 0.77 CTSB (0.33) —
SCHEMBL4187255 0.77 CTSB (0.31) —
SCHEMBL4209333 0.73 CTSB (0.46) —
SCHEMBL4209323 0.73 CTSB (0.46) —
SCHEMBL4187261 0.72 CTSB (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047244-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS I IDENIX PHARMACEUTICALS, INC. (US) 2009-02-19 — — US disclosed
Send feedback